Antigenic Sequences of Poliovirus Recognized by T Cells: Serotype-Specific Epitopes on VP1 and VP3 and Cross-Reactive Epitopes

on VP4 Defined by Using CD4+ T-Cell Clones by Mahon, Bernard P. et al.
Vol. 66, No. 12JOURNAL OF VIROLOGY, Dec. 1992, p. 7012-7020
0022-538X/92/127012-09$02.00/0
Copyright © 1992, American Society for Microbiology
Antigenic Sequences of Poliovirus Recognized by T Cells: Serotype-
Specific Epitopes on VP1 and VP3 and Cross-Reactive Epitopes
on VP4 Defined by Using CD4+ T-Cell Clones
BERNARD P. MAHON,* KERSI KATRAK,2 AND KINGSTON H. G. MILLS1
Division ofImmunobiology1 and Division of Virology,2 National Institute for Biological Standards and
Control, Blanche Lane, South Mimms, Potters Bar, Herfordshire EN6 3QG, United Kingdom
Received 26 May 1992/Accepted 2 September 1992
A panel of poliovirus-specific murine CD4+ T-cell clones has been established from both BALB/c (H-2d) and
CBA (H-2k) mice immunized with Sabin vaccine strains of poliovirus serotype 1, 2, or 3. T-celi clones were
found to be either serotype specific or cross-reactive between two or all three serotypes. Specificity analysis
against purified poliovirus proteins demonstrated that T-cell clones recognized determinants on the surface
capsid proteins VP1, VP2, and VP3 and the internal capsid protein VP4. Panels of overlapping synthetic
peptides were used to identify eight distinct T-ceil epitopes. One type 3-specific T-celi clone recognized an
epitope within amino acids 257 and 264 of VP1. Three T-cell epitopes corresponding to residues 14 to 28, 189
to 203, and 196 to 210 were identified on VP3 of poliovirus type 2. The remaining four T-celi epitopes were
mapped to an immunodominant region ofVP4, encompassed within residues 6 and 35 and recognized by both
H-2Z and H-2k mice. The epitopes on VP4 were conserved between serotypes, and this may account for the
predominantly cross-reactive poliovirus-specific T-cell response observed with polyclonal T-cell populations. In
contrast, T-cell clones that recognize epitopes on VP1 or VP3 were largely serotype specific; single or multiple
amino acid substitutions were found to be critical for T-celi recognition.
The generation of virus-specific neutralizing antibody is
considered the major mechanism of protection against po-
liovirus infection, and the success of poliovirus vaccines has
been directly attributed to the ability of the vaccines to
generate humoral immunity (5, 21). Consequently, the anti-
genic structure of the virus recognized by antibody is well
characterized, three serologically distinct serotypes (1, 2,
and 3) having been defined (21, 22). At least four neutralizing
antibody epitopes have been identified (21) and located on
the three-dimensional structure of the icosahedral virus
particle, which consists of 60 copies each of the four capsid
proteins VP1, VP2, and VP3 and the wholly internal protein
VP4 (4, 6). However, the recognition of poliovirus by T cells
and their possible role in the protective immune response
have received little attention.
T cells have important functions in immune protection
against viral diseases (16). Major histocompatibility complex
(MHC) class II-restricted CD4+ T cells proliferate upon
stimulation by antigen and secrete cytokines involved in the
regulation of immune responses, including the activation of
B cells to produce antibody (30). Although CD8+ MHC class
I-restricted T cells have largely been associated with cyto-
toxic T-lymphocyte (CTL) function (41), recent evidence
from cloned murine T cells suggests that a subpopulation of
CD4+ T cells, termed T-helper 1 (Thl), that secrete inter-
leukin-2 (IL-2) and gamma interferon (IFN--y) are also in-
volved in direct cell-mediated immunity, including lysis of
virally infected target cells (3, 23, 26). Another population,
termed Th2, release IL-4, IL-5, and IL-6 and are considered
to be mainly responsible for providing helper function for
antigen-specific antibody production (3, 23).
In studies using polyclonal T-cell populations, we and
others have previously demonstrated that immunization of
* Corresponding author.
mice with poliovirus in alum, in Freund's adjuvant, or
without adjuvant can generate broadly cross-reactive polio-
virus-specific T-cell responses (10, 12, 39). The findings also
suggested that a component of the T-cell response was
serotype specific. However, the use of polyclonal T-cell
populations in these studies precluded specificity analysis at
the amino acid level. A detailed study of T-cell fine speci-
ficity and function is possible only with the use of T-cell
clones.
In this report, we describe the generation of a panel of
poliovirus-specific murine CD4+ T-cell clones. Our findings
demonstrate that these clones either were specific for polio-
virus of a single serotype or were cross-reactive between
two or all three serotypes. Specificity analysis against iso-
lated capsid proteins revealed that a proportion of T-cell
clones recognized either VP1, VP2, or VP3, but the majority
(10 of the 18) recognized the internal capsid protein VP4,
hitherto not implicated in the immune response to poliovi-
rus. Using panels of overlapping synthetic peptides, we have
identified eight distinct T-cell epitopes and determined the
amino acid residues critical for their recognition.
MATERIALS AND METHODS
Virus preparations. Attenuated live poliovirus vaccine
strains of Sabin types 1, 2, and 3 were used throughout.
Viruses were propagated in Hep2c cells, and purified con-
centrates were obtained as described by Minor (20). Briefly,
infected tissue culture fluid was clarified by low-speed cen-
trifugation (3,000 x g), precipitated by using 0.4 g of
ammonium sulfate per ml, and purified through a 15 to 45%
sucrose gradient. Virus-bearing fractions were pooled and
centrifuged at 30,000 x g for 14 h; the pellets were resus-
pended in phosphate-buffered saline (PBS) and stored as
aliquots at -70°C. Virus infectivity was determined by using
the standard plaque assay (20), and protein concentrations
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were estimated by using the Bio-Rad protein assay kit 1
(Bio-Rad Laboratories Ltd., Watford, Hertfordshire, United
Kingdom).
Isolation of capsid proteins. Capsid proteins VP1, VP2,
VP3, and VP4 were isolated from sodium dodecyl sulfate
(SDS)-polyacrylamide gels in a form suitable for use in T-cell
assays as described by Katrak et al. (9). Briefly, disrupted
whole virus was loaded onto the center lanes and 10 ,ul of
Rainbow protein molecular weight markers (Amersham In-
ternational plc, Little Chalfont, Buckinghamshire, United
Kingdom) were loaded onto the outer lanes of an SDS-15%
polyacrylamide gel, and the gel was run for 16 h at 5 mA.
Bands corresponding to VP1, VP2, VP3, and VP4 were then
cut directly from the gel after location by alignment with the
visible molecular weight markers and by comparison with a
silver-stained test lane. Proteins were eluted by soaking the
gel fragments overnight at 4°C in 50% (vol/vol) PBS-distilled
water. This solution was then chilled on crushed ice, the
bulk of the SDS was removed by centrifugation, and the
eluted proteins were concentrated through either a Centri-
con 10 or Centricon 30 microconcentrator (Amicon Corp.,
Beverly, Mass.). The purity of separate fractions was as-
sessed by subjecting a sample of the eluted material to
SDS-polyacrylamide gel electrophoresis and demonstrating
that it was homogeneous (9). Eluted capsid proteins were
then coupled to latex microspheres (9), which were sterilized
by exposure to UV irradiation prior to use in T-cell prolif-
eration assays.
Synthetic peptides. Synthetic peptides (12-mers overlap-
ping by eight amino acid residues) corresponding to entire
sequences of VP1 of poliovirus type 3 and VP2 of type 2 (35)
were synthesized by using the multipin cleavable peptide
synthesis system (Cambridge Research Biochemicals,
Northwich, Cheshire, United Kingdom) by the method of
Maeji et al. (14). This set of peptides was synthesized with a
carboxyl-terminal ,3-alanine diketopiperazine group and
cleaved into neutral buffer. A further 48 synthetic peptides
corresponding to the entire sequence of VP3 of type 2
(15-mers overlapping by 8 residues) and to VP4 of type 2
(15-mers overlapping by 10 or 11 residues) were synthesized
commercially (Cambridge Research Biochemicals) accord-
ing to the sequence described by Toyoda et al. (35).
Mouse immunizations. Eight- to ten-week-old female
BALB/c (H-2) or CBA (H-2) mice were used for immuni-
zation. Each mouse was injected intraperitoneally with 108
PFU of virus (equivalent to approximately 1 FLg of protein),
administered either without adjuvant or precipitated with
alum. Fourteen days after primary immunization, the mice
received a booster immunization of an identical preparation.
Establishment of poliovirus-specific T-cell clones. T-cell
clones were established from the spleens of individual
BALB/c or CBA mice. Spleens were taken from mice 14
days after the in vivo boost, and cells were cultured at 2 x
106 ml-1 for 4 to 5 days in RPMI 1640 medium (supplement-
ed with 8% fetal calf serum) with 2 x 107 PFU of poliovirus
of the appropriate serotype ml-'. Surviving cells were
recultured for 7 days in fresh medium with autologous
irradiated spleen cells (2 x 106 ml-1) as feeders. T-cell lines
were established by maintaining these cultures at 105 cells
ml-' in a 4-day feed/7-da.r starve cycle, using alternatively 2
x 107 PFU of virus ml- with 2 x 106 irradiated syngeneic
spleen cells ml-' as antigen-presenting cells (APC) or feed-
ers alone. Cloning of T-cell lines was performed by limiting
dilution at 0.5 cell per well in 200-,ul volumes in 96-well
plates in the presence of APC (2 x 106 ml-1), virus (2 x 107
PFU ml-'), and 5% IL-2-containing supernatant (the latter
TABLE 1. Serotype specificity of T-cell clonesa
Proliferative response (103 cpm)
Clone H-2 hap- Immunizing to polioviruslotype serotype
No virus Type 1 Type 2 Type 3
Pol 2c-1 d 2 1.3 1.2 6.8 0.5
CB2.2-3 k 2 0.5 0.9 45.0 0.9
CB2.2-5 k 2 0.1 0.2 5.8 0.2
2KB-3 k 2 0.3 0.4 3.4 0.4
2KB-6 k 2 0.4 0.3 123.3 0.8
3N2s5.1 d 3 0.2 0.2 0.6 5.9
CB2.2-10 k 2 0.2 0.2 16.1 20.0
IN5.1 d 1 0.1 15.8 13.6 12.7
IN8.44 d 1 0.1 82.5 103.3 84.2
CB2.1-3 k 2 0.3 74.6 87.0 64.5
CB2.1-6 k 2 0.2 17.0 10.5 11.3
CB2.2-4 k 2 0.2 12.4 69.2 66.1
CB2.2-8 k 2 0.2 5.7 14.4 11.9
2KA-1 k 2 0.2 7.4 40.8 47.8
2KA-2 k 2 0.7 24.5 47.5 29.3
2KA-5 k 2 0.2 5.0 4.8 7.3
2KB-4 k 2 0.2 14.4 12.8 10.8
3KC-1 k 3 2.9 50.4 54.2 44.3
a T-ceil clones were cultured with polioviruses at dilutions ranging from
10-6 to 10-9 PFU ml-' for 2 to 3 days and then pulsed for 4 to 6 h with
[3H]thymidine. Results are expressed as mean counts per minute for triplicate
cultures at the optimum antigen concentration.
prepared from concanavalin A-activated rat spleen cells). A
further 25 ,ul of IL-2-containing supernatant was added to
cultures 5 days later. The clones were restimulated after a
further 7 days of incubation and progressively expanded to
25-cm3 flasks. Clones were maintained by restimulation at an
initial concentration of 105 cells ml-1' with virus and APC
every 10 days, with IL-2-containing supernatant and feeders
added 4 days after antigen stimulation. The specificity of
T-cell clones was tested in a proliferation assay.
T-cell proliferation assay. T-cell clones were rested for 10
days after stimulation with virus before assay. T-cell clones
(2 x 104) were cultured with antigen (viruses, isolated virus
capsid proteins, or synthetic peptides) in the presence of 4 x
i0S feeder cells as APC in 200-iLl volumes in flat-bottom
96-well microtiter plates. Controls included medium alone or
a lysate prepared from noninfected Hep2C cells. Cultures
were incubated for 2 or 3 days and pulsed for the last 4 to 6
h with 0.5 ,uCi of [3H]thymidine. Cells were harvested onto
filter paper by using an automated cell harvester, and
[3H]thymidine incorporation was measured by liquid scintil-
lation counting. Results are expressed as mean counts per
minute for triplicate cultures.
RESULTS
Serotype specificity of poliovirus-specific T-cell clones. A
panel of poliovirus-specific CD4+ T-cell clones was estab-
lished by limiting dilution of bulk cultures or T-cell lines
derived from spleen cells of individual BALB/c or CBA mice
immunized with the Sabin strain of poliovirus serotype 1, 2,
or 3. All clones studied were of the Thy 1+ CD4+ CD8-
phenotype (data not shown). The serotype specificities of 18
T-cell clones derived from nine mice were examined by
testing their proliferative responses against the three differ-
ent poliovirus serotypes (Table 1 and Fig. 1) and shown to
fall into three specificity groups (summarized in Table 2).
Five T-cell clones (Pol 2c-1, CB2.2-3, CB2.2-5, 2KB-3, and
2KB-6) were specific for poliovirus type 2 but failed to
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CB 2.2-10 TABLE 2. Poliovirus capsid protein specificity of T-cell clones
Specificity'
Clone Serotype Capsid protein
1 2 3 VP1 VP2 VP3 VP4
Pol 2c-1 - + - + - - -
CB2.2-3 - + - - - + -
CB2.2-5 - + - - - + -
2KB-3 - + - - - + -
2KB-6 - + - - - + -
3N2s5.1 - + + + - - -
CB2.2-10 - + + - - + _
IN5.1 + + + - - - +
IN8.44 + + + - + -
CB2.1-3 + + + - - - +
CB2.1-6 + + + - - - +
CB2.2-4 + + + - - - +
CB2.2-8 + + + - - - +
2KA-1 + + + - - - +
2KA-2 + + + - - - +
2KA-5 + + + - - - +
2KB-4 + + + - - - +
3KC-1 + + + - - - +
a Positive (+), intermediate (±), and negative (-) proliferative responses
correspond to stimulation indices of >10, 2.5 to 10, and <2.5, respectively.
Results are the summarized from three independent experiments.
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but not as strongly, to the overlapping peptide, VP1 253-264
type 1 or type 3 over a (Fig. 2). This result suggests that the T-cell epitope is
(Fig. 1A). T-cell clone centered on residues Arg-257 to His-264. This T-cell clone
)virus types 2 and 3 but responded weakly to poliovirus type 2 and not at all to type
), whereas clone 3N2s5.1 1 (Fig. 1C). An examination of the sequences of the corre-
I to recognize type 1, and sponding regions of poliovirus type 1 or type 2 (Table 3)
tigen concentrations (Fig. demonstrates that the substitution of Ile-258 with Val in type
;were fully cross-reactive 2 substantially reduces stimulation of T-cell clone 3N2s5.1
id Fig. 1D). and that a second substitution, Met-260 to Leu, in poliovirus
ioliovrus capsid proteins. type 1 completely abrogates T-cell recognition.
he preparative separation Serotype-specific epitopes on VP3. T-cell clone CB2.2-10,
cell assays (9), poliovirus derived from a CBA (H-2") mouse, responded to a single
'3 and the internal capsid peptide, VP3 189-203 of poliovirus type 2 (Fig. 3A), over a
.d for specificity analysis range of antigen concentrations (Fig. 4A). The amino acid
he results summarized in sequence of this peptide and of the corresponding regions of
or fully serotype-specific poliovirus types 1 and 3 are shown in Table 4. The specificity
VP3. One cross-reactive pattern of this T-cell clone for virus variants indicated that a
VP2, while the remaining single substitution (Val -- Ile) at position 198 in type 3 is
clones recognized VP4. tolerated, whereas a second change (Met -- Val) at position
derived from six of nine 192 in type 1 completely abrogates the T-cell response (Table
d to VP4, suggesting that 4). Another H-2k T-cell clone, 2KB-6, specific for poliovirus
dominant for murine T type 2, recognized the overlapping peptide VP3 196-210 (Fig.
3B and 4B). A comparison of the amino acid sequences of
rnthetic peptides. From a the three Sabin strains of poliovirus in this region (Table 4)
tapped to distinct poliovi- shows considerable variation, with two sequence changes in
ed for specificity against type 1 and five changes in type 3.
g to the entire sequence of Three further clones, CB2.2-3, CB2.2-5, and 2KB-3, de-
orresponding to VP1 of rived from CBA (H-2k) mice, recognized a single peptide
e of testing with clone Pol corresponding to residues 14 to 28 of VP3 of poliovirus type
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FIG. 2. Proliferative responses of T-cell clone 3N2s5.1 against overlapping synthetic peptides corresponding to the sequence of VP1 of
poliovirus type 3. Peptides and whole virus were tested at a concentration of 1 ,ug ml-1.
2. As clones CB2.2-3 and CB2.2-5 were derived from the
same animal and displayed identical specificity patterns,
only the results for clones CB2.2-3 and 2KB-3 are shown
(Fig. 3C and D). Each of the T-cell clones responded to
poliovirus type 2 but not to type 1 or 3. An examination of
the amino acid sequences in the region of peptide 14-28
revealed that substitutions at position 19 and at either
TABLE 3. CD4+ T-cell epitope on VP1 of poliovirus type 3
recognized by T-cell clone 3N2s5.1
Antigen Sequencea clonfeofT-cel
Poliovirus 249 272
Type 3 PTKVTSKVBIYMKPKHVBVWCPRP +
Type 2 --RL---I-V-------------- +
Typel -------I-V-L----I------- -
Peptide VP1
249-260 ----------
253-264 +
257-268 +
261-272
a Amino acid sequences of poliovirus types 1, 2, and 3 (35) and of the
overlapping peptides of type 3 are shown in single-letter code (amino acid
numbering according to the type 3 sequence), with residue substitutions
within the minimal T-cell determinant indicated by underlining.
b Results summarized from Table 1, Fig. 1, and Fig. 2.
position 16 or position 25 in types 1 and 3, respectively,
abrogates recognition by these T-cell clones (Table 5).
Cross-reactive epitopes on VP4. Nine of the ten cross-
reactive T-cell clones that recognize VP4 were tested against
twelve overlapping 15-mer peptides corresponding to the
entire sequence of VP4 of poliovirus type 2. T-cell clone
CB2.2-4, derived from a CBA (H-2) mouse, proliferated in
response to a single peptide, VP4 6-20 (Fig. 5A). Three
further H-t clones, 2KA-1 and 2KB-4, derived from type
2-immunized mice, and clone 3KC-1, derived from a type
3-immunized mouse, proliferated in response to one peptide
corresponding to residues 11 to 25 of VP4 (Fig. SB and C).
Clone IN5.1, derived from a BALB/c (H-2") mouse, also
responded to this peptide, but in addition recognized an
overlapping peptide VP4 16-30 (Fig. SD). This finding sug-
gests that T-cell clone IN5.1 recognized an overlapping
epitope encompassed within residues Ser-16 and Ile-25. The
remaining four T-cell clones, CB2.1-3, CB2.1-6, 2KA-2, and
2KA-5, all responded to the peptide corresponding to resi-
dues 21 to 35, indicating the presence of at least one further
epitope in this region of VP4 (Fig. 5E and F). As T-cell
clones 2KA-2 and 2KA-5 are derived from the same animal
and exhibit identical specificity, and likewise clones CB2.1-3
and CB2.1-6, only the results for 2KA-5 around CB2.1-3 are
shown in Fig. 5. A single amino acid substitution within
residues 6 and 35 in poliovirus type 3 (Arg-34 to Lys) does
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FIG. 3. Proliferative responses of the indicated T-cell clones
against overlapping synthetic peptides corresponding to the se-
quence of VP3 of poliovirus type 2. Peptides and whole virus were
tested at a concentration of 1 p,g mn-1.
not affect recognition by these fully cross-reactive T-cell
clones (Table 6).
DISCUSSION
The findings of this study demonstrate that T cells recog-
nize epitopes on each of the four poliovirus capsid proteins,
including an immunodominant region of VP4. Fine specific-
ity analysis with a panel of CD4+ T-cell clones revealed that,
analogous to monoclonal antibody binding, T-cell recogni-
tion of the surface capsid proteins VP1 and VP3 was affected
by sequence variation between viruses of different sero-
types. In contrast, T-cell clones specific for the conserved
internal capsid protein VP4 were cross-reactive between
each of the three serotypes. To our knowledge, this study
constitutes the first description of poliovirus T-cell specific-
ity at the clonal level and provides the first evidence for a
possible role for VP4 in immunity to poliovirus.
A number of studies have alluded to a role for T cells in
immunity to poliovirus through their helper function in
antibody production (7, 8, 37), and poliovirus-specific T-cell
responses have been demonstrated in studies using lymph
nodes or spleen cells from immunized mice (10, 12, 39).
Furthermore, a single T-cell epitope has been identified on
O ~-
0.01 0.1 10
2KB-6
0.001 0.01 0.1 1 10
Peptide Concentration (jig per ml)
FIG. 4. Recognition of overlapping poliovirus VP3 peptides 189-
203 and 196-210 by T-cell clones CB2.2-10 and 2KB-6.
poliovirus VP1 by using a polyclonal T-cell preparation (12).
In the present investigation, we used a panel of T-cell clones
and overlapping synthetic peptides in a detailed analysis of
the antigenic sequences of poliovirus recognized by T cells.
From a total of 18 CD4+ T-cell clones characterized, 10
recognized the internal capsid protein VP4. The four
epitopes defined on VP4 were all found toward the N-termi-
nal region, encompassed within residues 6 and 35, a se-
quence which is highly conserved between the three polio-
TABLE 4. Two overlapping CD4+ T-cell epitopes on VP3 of
poliovirus type 2 recognized by T-cell clones CB2.2-10 and 2KB-6
Response of
Antigen Sequencea T-cell cloneb:
CB2.2-10 2KB-6
Poliovirus 189 210
Type 2 YISMFYQTRVVVPLSTPRKMDI + +
Type 3 ---------KI-------SK-M +
Type 1 ---V-----I--------E---
Peptide VP3
182-196 --------- -
189-203 ----------- +
196-210 --------------- - +
203-217 -------- - -
a As for Table 3 except that overlapping synthetic peptides are based on the
sequence and numbering of poliovirus type 2 (35).b Results summarized from Table 1, Fig. 1, and Fig. 3.
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TABLE 5. CD4+ T-cell epitope on VP3 of poliovirus type 2 recognized by T-cell clones CB2.2-3 CB2.2-5, and 2KB-3
Response of T-cell cloneb:
Antigen Sequencea
CB2.2-3 CB2.2-5 2KB-3
Poliovirus 7 35
Type 2 TPGSNQYLTADNYQSPCAIPEFDVTPPID + + +
Type1 -----------_F-----_L ----------
Type 3 ---------S--H-----------------
Peptide VP3
7-21
14-28 + + +
21-35
a As in Table 4.
b Results summarized from Table 1, Fig. 1, and Fig. 3.
virus serotypes (35). A single amino acid sequence alteration
in this region (Arg-34 to Lys in poliovirus type 3) had no
effect on T-cell recognition. Studies with polyclonal T cells
(10, 12, 39) have indicated the existence of uncharacterized
T-cell sites common to all poliovirus serotypes. The result of
the present study suggests that VP4 may be the major target
for cross-reactive T cells. Ten T-cell clones derived from six
individual H-2k or H-2" mice recognized the N-terminal
region of VP4. T-cell recognition of conserved internal viral
s A
4 -
3-
2
1-1.
.E
0
co
0
C
0
I5-
0
5
4
3
2
0
10I
8
6
4
2
0
CB2.2-4
,.. ~ ~ ..
.c
3KC-1
.C
IL
10
8
6
4
2
0
6
5
4,
3
2
1
I0
10
8
6
4.
2
0
B
D
2KA-1
IN5.1
A|jl_.
F
I
2KA-5
I,
O 0 Le) Ou L)u O 0) 't0>awooLC,oLg,OLOOC)O )eCC.J-c C') C.) "t qt%tLOL O t D
. I_cbo b- - 0 a
0.
'Tl L
Peptide Peptide
FIG. 5. Proliferative responses of the indicated T-cell clones
against overlapping synthetic peptides of VP4 of poliovirus type 2.
Peptides and whole virus were tested at a concentration of
1 pg ml-,.
II
proteins is well established from studies with other viruses
such as human immunodeficiency virus and influenza virus,
for which the Gag protein and nucleoprotein have been
shown to contain both CD4+ and CD8+ T-cell epitopes (16,
18, 25, 33, 34).
In contrast to the fully cross-reactive T-cell responses to
VP4, T-cell clones specific for VP1 or VP3 responded only to
the immunizing serotype or showed limited cross-reactivity
between poliovirus types 2 and 3. One T-cell epitope was
defined in a variable region of VP1 or poliovirus type 3 by
using clone 3N2s5.1, generated from a type 3-immunized
H-2d mouse. The minimum epitope recognized by this T-cell
clone is encompassed within residues 257 and 264, which on
the three-dimensional structure of poliovirus is located on
the I strand of VP1, a region of 1 sheet (4, 6). An Ile-to-Val
substitution at position 258 in the corresponding sequence of
poliovirus type 2 substantially reduced the recognition of
this virus, while a second sequence alteration at position 260
of Met to Leu in the type 1 sequence completely abrogated
the proliferative response of this clone. The H-2d T-cell
epitope previously identified on VP1 of poliovirus strain
Mahoney type 1 (12) is adjacent to the main neutralizing
antibody site on VP1 (site 1, amino acids 89 to 104). The
T-cell epitope on VP1 identified in the present study, al-
though not close in the linear sequence, forms part of an
adjacent loop region that includes residue 253, which has
been implicated in the monoclonal antibody binding to site 1
(6, 22).
T-cell epitopes identified on VP3 also map to variable
regions of the protein. One epitope on VP3 of poliovirus type
2 recognized by three distinct H-2t T-cell clones was encom-
passed within residues 14 and 28, which, by analysis with the
structure of Mahoney type 1 (6) and Sabin type 3 (4), forms
part of the internal N-terminal tail of VP3. The other two
T-cell epitopes were mapped to overlapping sequences in
VP3, corresponding to amino acids 189 to 208 and 196 to 210,
which form part of the internal H strand and the exposed H-I
loop regions. This loop region has also been shown to
include residues critical for monoclonal antibody binding to
poliovirus type 2 (36). An overlap between T-cell and B-cell
epitopes has been described for influenza hemagglutinin; it
has been suggested that B cells may function to direct the
T-cell response to specific sites on the viral protein (1, 19).
The proliferative response of clone 2KB.6, which recog-
nized an epitope corresponding to residues 196 to 210
located on the external loop of VP3, was abrogated by the
considerable amino acid sequence variation in this region
(two amino acid sequence changes in type 1 and five changes
in type 3 in comparison with type 2). It has been suggested
li
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TABLE 6. Four overlapping CD4' T-cell epitopes on VP4
Response of T-cell clone(s)b:.
Antigen Sequence' B.- 3KG-i,2KB54 CB2.1-3, 2KA-5,CB2.2-4 2KA-1,2KB-4,CB2.1-6, 2KA-2,
Poliovirus 6 35
Type 2 SSQKVGAHENSNRAYGGSTINYTTINYYRD + + + +
Type 1------- -----------+ + + +
Type 3----------------K + + + +
Peptide VP4
6-20-+-----------
11-25 + +
16-30
21-35.-----------+
a As in Table 4.
b Results summarized from Table 1, Fig. 1, and Fig. 5.
that amino acid sequence variation in the external loop
regions of poliovirus indicate that these sites are targets for
immune recognition (25). However, we have also demon-
strated that T-cell responses to epitopes in the internal
regions of VP1 and VP3, which are unlikely to be recognized
by neutralizing antibodies, are also affected by antigenic
variation between poliovirus serotypes. Although the se-
quence variation in internal proteins may be the result of
compensatory changes necessary for the maintenance of the
structural integrity of the viral capsid, it is also possible that
MHC class 11-restricted T cells, like antibodies, play a role in
immune selection, resulting in antigenic variation in poliovi-
ruses. Studies with lymphocytic choriomeningitis virus (28),
human immunodeficiency virus (27), and influenza virus (1,
19) have demonstrated that mutations in internal as well as
surface proteins can abrogate virus-specific CD4' and CD8'
T-cell responses. Amino acid sequence changes within the
minimum T-cell epitope may affect T-cell recognition by
inhibiting the peptide interaction with the MHC molecule or
the T-cell receptor. Alternatively, it is possible that substi-
tutions in flanking sequences prevent T-cell recognition
through their effects on antigen processing.
Since there is no evidence that Sabin type 1, 2, and 3
strains of poliovirus can replicate in mice (11, 29), the
immunization schedule that we have used in this study is
unlikely to generate T cells that recognize antigen processed
by the endogenous route. However, as CD4' T cells nor-
mally recognize peptides processed from exogenous anti-
gens, the murine model that we used should provide valuable
information on the class II-restricted T-cell repertoire for
poliovirus. The functional significance of poliovirus-specific
CD4' T cells in protection against poliovirus infection in
humans remains to be defined.
The helper activity of CD4' T cells is well documented.
Studies with murine T-cell clones have shown that the Th2
subpopulation of murine CD4' T cells secrete the lymphok-
ines IL-4, IL-5, and IL-6, which regulate immunoglobulin G
and immunoglobulin A production by controlling immuno-
globulin class switching and B-cell differentiation (3, 23). It
has been reported that Th cells specific for core antigens of
influenza virus and hepatitis B virus can provide helper
function for a protective antibody response to the surface
proteins (15, 32). We have also suggested that the induction
of cross-reactive poliovirus-specific Th cells may allow an
enhanced primary neutralizing antibody response to protec-
tive epitopes following exposure to either a second serotype
or a new virus variant (10). Therefore, CD4' cells against
conserved epitopes on VP4 may play a role in broadly
protective immune defense against poliovirus infection.
However, studies with human and simian immunodeficiency
viruses have shown that this type of intrastructural intermo-
lecular help does not always operate between surface and
internal viral proteins (17).
An alternative role for poliovirus-specific CD4' T cells
may reside in functions associated with the Thl subpopula-
tion,, which secrete IL-2, lymphotoxin, and IFN--y (23). Thl
cells have been shown to display delayed-type hypersensi-
tivity and in vitro cytotoxic activity (23). Furthermore, an in
vivo role for CD4' MHC class IT-restricted CTL specific for
lymphocytic choriomeningitis virus has recently been dem-
onstrated (24). Although the highly lytic nature of poliovirus
infection of cells in tissue culture argues against a role for
CTL in vivo, class I-restricted CD8' CTL have been dem-
onstrated against other picornaviruses. Virus-specific CTL
have been shown to play a role in viral clearance and in
immune pathology following infection of mice with coxsack-
ievirus B3 or Theiler's murine encephalomyelitis virus (13,
31, 40). Poliovirus-specific CD4' Thl cells could function
through IFN--y production to increase MHC class I or class
II expression on the surface of poliovirus-infected cells of
the central nervous system such as neurons (38), thus
enhancing their susceptibility to lysis by CD8' or CD4'
CTL. The documented inflammatory response in the form of
a mononuclear cell infiltrate in the central nervous system
after intracerebral inoculation of mice with mouse-adapted
poliovirus (8) provides further circumstantial evidence for
the involvement of Thl cells. The cytokines IFN--y and
lymphotoxin produced by Thl cells have been implicated in
the migration of lymphocytes and macrophages into inflam-
matory sites (23). Current investigations of the in vitro
function and cytokine production by the murine CD4' T-cell
clones described in this report, as well as future experiments
on T-cell 'function in vivo with use of transgenic mice
expressing poliovirus receptor gene (29), may he-lp to eluci-
date the relative roles of T-cell subpopulations in immunity
to poliovirus.
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